20n
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Accelerator/Inc
LATEST DEAL TYPE
$120K
LATEST DEAL AMOUNT
8
INVESTORS
Description
Operator of a computational synthetic biology company. The company uses algorithms to engineer microbes to produce chemicals with therapeutic health and industrial biotech applications. It provides the computational systems that predict DNA design for novel industrial biotech and health applications.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Application Software
Primary Office
- San Francisco, CA
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore 20n’s full profile, request a free trial.
20n Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 24-Mar-2015 | $120K | 00000 | 00.000 | Completed | Startup |
| 1. Early Stage VC | Completed | Startup |
20n Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Y Combinator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Blumberg Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Eric Kwan | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Great Oaks Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Khosla Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
20n Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Saurabh Srivastava Ph.D | Co-Founder & Chief Executive Officer |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »